Cargando…
An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain
Neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD), and Dementia with Lewy bodies (DLB), display an accumulation of proteins including α-synuclein aggregates in cortical and subcortical regions of the brain. PD is a complex, progressive disease which inv...
Autores principales: | Pacheco, C., Aguayo, L. G., Opazo, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429068/ https://www.ncbi.nlm.nih.gov/pubmed/22934048 http://dx.doi.org/10.3389/fphys.2012.00297 |
Ejemplares similares
-
Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization
por: Roostaee, Alireza, et al.
Publicado: (2013) -
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
por: Gallegos, Scarlet, et al.
Publicado: (2015) -
N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity
por: Zhou, Lingyan, et al.
Publicado: (2022) -
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity
por: Ysselstein, Daniel, et al.
Publicado: (2017) -
Single point mutations at the S129 residue of α-synuclein and their effect on structure, aggregation, and neurotoxicity
por: Pandit, Esha, et al.
Publicado: (2023)